WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that the Company’s President and Chief Executive Officer, Noah D. Beerman, will present a corporate overview at the 17th annual Future Leaders in the Biotech Industry investment conference, on Thursday, April 8, 2010 at 3:30 pm ET.
